收藏切换
A systematic review of the efficacy and safety of pentoxifylline in the treatment of diabetic neuropathy
收藏切换
Jing HUANG, Shuyuan XIONG, Shenglan DING, Qingfeng CHENG, Zhiping LIU*
World Clinical Drug | 2022, 43(2) : 155 - 163
Less
收藏切换
World Clinical Drug | 2022, 43(2): 155-163
• Article •
A systematic review of the efficacy and safety of pentoxifylline in the treatment of diabetic neuropathy
Full
Jing HUANG, Shuyuan XIONG, Shenglan DING, Qingfeng CHENG, Zhiping LIU*
Affiliations
  • Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Published: 2022-02-10 doi: 10.13683/j.wph.2022.02.009
Outline
收藏切换
Objective

To evaluate the efficacy and safety of pentoxifylline (PTX) in the treatment of diabetic neuropathy (DN).

Methods

PubMed, Embase, Cochrane Library, Web of Science, Ovid, Chinese Biomedical Literature Database, VIP database, Wanfang database and China National Knowledge Internet were systematically searched to collect the sudies on the treatment of DN with PTX. The search duration was from the establishment of the database to December 10, 2019, and the languages were limited to Chinese and English. Two researchers independently screened the literature, evaluated the methodological quality of the included sudies, extracted the data, and then conducted qualitative analysis.

Results

A total of 16 original studies were included, with a total of 928 subjects. There were 11 randomized controlled trials and 5 quasi-randomized controlled trials. The main outcome indicators included in the study were hemorheology, nerve conduction velocity, current perception threshold, pain, Michigan neuropathy screening instrument, blood glucose, blood pressure, blood lipid, erectile function and adverse reactions.

Conclusion

PTX can increase erythrocyte deformability, reduce whole blood viscosity, plasma viscosity, maximum platelet aggregation rate, fibrinogen and erythrocyte aggregation index in patients with DN. It can be used as an adjuvant treatment for DN and is relatively safe.

pentoxifylline  /  diabetic neuropathy  /  system evaluation
黄静, 熊淑媛, 丁胜兰, 程庆丰, 刘智平. 己酮可可碱治疗糖尿病神经病变效果与安全性系统评价. 世界临床药物, 2022 , 43 (2) : 155 -163 . DOI: 10.13683/j.wph.2022.02.009
Jing HUANG, Shuyuan XIONG, Shenglan DING, Qingfeng CHENG, Zhiping LIU. A systematic review of the efficacy and safety of pentoxifylline in the treatment of diabetic neuropathy[J]. World Clinical Drug, 2022 , 43 (2) : 155 -163 . DOI: 10.13683/j.wph.2022.02.009
Year 2022 volume 43 Issue 2
16
5
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.02.009
  • Receive Date:2021-05-16
  • Online Date:2026-11-19
  • Published:2022-02-10
Article Data
Affiliations
History
  • Received:2021-05-16
Affiliations
    Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.02.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT